Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Neuroprotective Activity of Hypericum perforatum and Its Major Components.

Oliveira AI, Pinho C, Sarmento B, Dias AC.

Front Plant Sci. 2016 Jul 11;7:1004. doi: 10.3389/fpls.2016.01004. eCollection 2016 Jul 11. Review.

2.

Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels.

Leuner K, Li W, Amaral MD, Rudolph S, Calfa G, Schuwald AM, Harteneck C, Inoue T, Pozzo-Miller L.

Hippocampus. 2013 Jan;23(1):40-52. doi: 10.1002/hipo.22052. Epub 2012 Jul 20.

3.

Preferences for Professional Assistance for Distress in a Diverse Sample of Older Adults.

Gum AM, Ayalon L, Greenberg JM, Palko B, Ruffo E, Areán PA.

Clin Gerontol. 2010;33(2):136-151. Epub 2010 Mar 22.

4.

Treatment of depressive disorders in primary care--protocol of a multiple treatment systematic review of randomized controlled trials.

Linde K, Schumann I, Meissner K, Jamil S, Kriston L, Rücker G, Antes G, Schneider A.

BMC Fam Pract. 2011 Nov 15;12:127. doi: 10.1186/1471-2296-12-127. Review.

5.

Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.

Wang JT, Hoffman B, Blumenthal JA.

Expert Opin Pharmacother. 2011 Jan;12(1):85-98. doi: 10.1517/14656566.2010.513701. Epub 2010 Aug 17. Review.

6.

Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

Borrelli F, Izzo AA.

AAPS J. 2009 Dec;11(4):710-27. doi: 10.1208/s12248-009-9146-8. Epub 2009 Oct 27. Review.

7.

The use of herbal medications and dietary supplements by people with mental illness.

Niv N, Shatkin JP, Hamilton AB, Unützer J, Klap R, Young AS.

Community Ment Health J. 2010 Dec;46(6):563-9. doi: 10.1007/s10597-009-9235-2. Epub 2009 Aug 18.

8.

The CAM network - Challenges and opportunities.

Rieder MJ.

Paediatr Child Health. 2005 Apr;10(4):201-2. No abstract available.

9.

Postnatal depression.

Craig M, Howard L.

BMJ Clin Evid. 2009 Jan 26;2009. pii: 1407. Review.

10.

Identification of human intracellular targets of the medicinal Herb St. John's Wort by chemical-genetic profiling in yeast.

McCue PP, Phang JM.

J Agric Food Chem. 2008 Nov 26;56(22):11011-7. doi: 10.1021/jf801593a.

11.

Evaluating the quality of randomized controlled trials that examine the efficacy of natural health products: a systematic review of critical appraisal instruments.

Whelan AM, Jurgens TM, Lord L.

Evid Based Complement Alternat Med. 2009 Dec;6(4):441-8. doi: 10.1093/ecam/nem186. Epub 2008 Jan 18.

12.

Herbal medicines: can we do without pharmacologist?

Calapai G, Caputi AP.

Evid Based Complement Alternat Med. 2007 Sep;4(Suppl 1):41-3. doi: 10.1093/ecam/nem095.

13.

St John's wort versus paroxetine for depression.

Jurcic J, Pereira JA, Kavanaugh D.

Can Fam Physician. 2007 Sep;53(9):1511-3. No abstract available.

14.

Human immunodeficiency virus and depression in primary care: a clinical review.

Colibazzi T, Hsu TT, Gilmer WS.

Prim Care Companion J Clin Psychiatry. 2006;8(4):201-11.

15.

Contemporary alternatives to plant estrogens for menopause.

Geller SE, Studee L.

Maturitas. 2006 Nov 1;55 Suppl 1:S3-13. Epub 2006 Aug 1. Review.

17.

Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds.

Schmitt LA, Liu Y, Murphy PA, Birt DF.

J Agric Food Chem. 2006 Apr 19;54(8):2881-90.

18.

Botanical and dietary supplements for menopausal symptoms: what works, what does not.

Geller SE, Studee L.

J Womens Health (Larchmt). 2005 Sep;14(7):634-49. Review.

Supplemental Content

Support Center